Project: Ghana Emergency Medicine Collaborative Document Title: Sepsis in the ED Author(s): Vijay Kairam, MD License: Unless otherwise noted, this material.

Slides:



Advertisements
Similar presentations
Author(s): Prachi Agarwal M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Advertisements

Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Author(s): Paul Conway, License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Caroline Richardson, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): John Doe, MD; Jane Doe, PhD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): John Doe, MD; Jane Doe, PhD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Templates for editing U-M OER Materials
Author(s): Paul Conway, License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): David Ginsburg, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Module: Leadership Training Workshop for Health Professionals Organization: East Africa HEALTH Alliance Author(s): Prof. John T. Kakitahi, Resource.
Project: Ghana Emergency Medicine Collaborative Document Title: Basic Life Support Author(s): Rockefeller A. Oteng (University of Michigan), MD 2012 License:
Author: Jonathan Trobe, MD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution 3.0.
Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: Open Educational Resources Author(s): University of Michigan Department of Emergency Medicine.
Project: Ghana Emergency Medicine Collaborative Document Title: Anaphylaxis Author(s): Peter Moyer (Boston University), MD, MPH 2012 License: Unless otherwise.
Module: Public Health Disaster Planning for Districts Organization: East Africa HEALTH Alliance, Author(s): Dr. Roy William Mayega (Makerere.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): MELO 3D Project Team, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Module: Leadership Training Workshop for Health Professionals Organization: East Africa HEALTH Alliance Author(s): Prof. William Bazeyo, Resource.
Project: Ghana Emergency Medicine Collaborative Document Title: Approach to Acute Chest Pain Author(s): Rockefeller Oteng (University of Michigan), MD.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Joan Durrance, 2009 License: Unless otherwise noted, this material is made available under the terms of the Attribution - Non-commercial 3.0.
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Project: Ghana Emergency Medicine Collaborative Document Title: Seizures Author(s): Ryan LaFollette, MD (University of Cincinnati), 2013 License: Unless.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Attribution: Kim Eagle, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Kate Saylor, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: John Williams, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: My Bougie and Me Author(s): Vijay Kairam (University of Utah), MD 2012 License: Unless.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Louis D’Alecy, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): Steve Jackson, 2009 License: Unless otherwise noted, this material is made available under the terms of the Attribution - Noncommercial - Share.
Author(s): Gabriel Krieshok, Alex Pompe, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Louis D’Alecy, 2009
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
1 Author(s): Andrew Rosenberg
Author: Michael Jibson, M.D., Ph.D., 2009
Author(s): John Doe, MD; Jane Doe, PhD, 2009
Author(s): Rajesh Mangrulkar, MD, 2009
Author(s): Paul Conway, PhD, 2010
Author: Michael Jibson, M.D., Ph.D., 2009
Attribution: University of Michigan Medical School, Department of Internal Medicine License: Unless otherwise noted, this material is made available under.
1 Author(s): Rebecca W. Van Dyke, M.D., 2012
Author(s): Joan Durrance, 2009
1 Author(s): Rebecca W. Van Dyke, M.D., 2012
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available.
Attribution: Department of Neurology, 2009
Author: Michael Jibson, M.D., Ph.D., 2009
Presentation transcript:

Project: Ghana Emergency Medicine Collaborative Document Title: Sepsis in the ED Author(s): Vijay Kairam, MD License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. These lectures have been modified in the process of making a publicly shareable version. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers. 1

Attribution Key for more information see: Use + Share + Adapt Make Your Own Assessment Creative Commons – Attribution License Creative Commons – Attribution Share Alike License Creative Commons – Attribution Noncommercial License Creative Commons – Attribution Noncommercial Share Alike License GNU – Free Documentation License Creative Commons – Zero Waiver Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your jurisdiction may differ Public Domain – Expired: Works that are no longer protected due to an expired copyright term. Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105) Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain. Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your jurisdiction may differ Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair. To use this content you should do your own independent analysis to determine whether or not your use will be Fair. { Content the copyright holder, author, or law permits you to use, share and adapt. } { Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. } { Content Open.Michigan has used under a Fair Use determination. } 2

Sepsis in the ED Vijay Kairam MD Univeristy of Utah Emergency Medicine 3

Case 1 75 yo male arrives to the Orange Zone, complains of chest pain and shortness of breath. VS P 110, BP 95/65, R 20 SaO2 91% PE: Pale, diaphoretic, talking in full sentences 4

Source Undetermined 5

Case 2 65 year old female, had the sudden onset of dysarthria, R sided hemiparesis about 1.5 hrs ago VS P 75 BP 155/75 R 16 SaO2 96% PE: Airway intact but drooling, R sided hemiparesis 6

Case 3 76 yo female, has been feeling generally weak for the last few days. Thought she had a fever today and came to ED. VS: 88/54, hr 105, t 38.5, 95% RA PE: Seems drowsy but will talk when stimulated, nl chest and abd exam 7

Who is most likely to die in the next 30 days? Case 1 Case 2 Case 3 Acute MI - 9% Cerebrovascular Accident - 15% Septic Shock - 40% 8

Sepsis, Some Definitions SIRS: Systemic Inflammatory Response Syndrome Sepsis: SIRS + presence of known or suspected infection Severe Sepsis: Sepsis + end organ dysfunction Septic Shock: Sepsis + Shock 9

SIRS = 2 or more T >38 or < 36 HR > 90 RR > 20 WBC > 12 K or < 4 K 10

What does the pt in case 3 have? 88/50, hr 105, t 38.5, rr 20, 95% RA 11

What if her vitals were… 100/65, hr 105, rr 20, t 38.5, 95% on RA 12

Sepsis Demographics 750,000 cases of severe sepsis in North America each year 200,000 cases of septic shock each year 30-35% mortality for severe sepsis 50% mortality for septic shock Surviving Sepsis Campaign 13

Pathophysiology of Sepsis Triggered by bacterial toxins and inflammatory cascade Progressive end-organ dysfunction - Tissue hypoxia from inadequate O2 delivery - Mitochondrial dysfunction - Microthrombi deposition at capillary level Distributive shock 14

Severe Sepsis End-organ dysfunction - Altered mental status - Decreased urine output - Acute lung injury - Coagulopathy - Cardiac dysfunction Lactic Acidosis 15

Early Goal Directed Therapy Patients with severe sepsis or septic shock (sbp 4) Randomized to normal ED care vs EGDT Rivers et al N Eng J Med: 345(19):

Lena Carleton, University of Michigan Original Image: Rivers et al N Eng J Med: 345(19):

Early Goal Directed Therapy in the Treatment of Severe Sepsis and Septic Shock Lena Carleton, University of Michigan Original Image: Rivers et al N Eng J Med: 345(19):

EGDT Decreases Mortality In Hospital Mortality –Standard Therapy: 46.5% –EGDT: 30.5% –ARR: 16.5% –NNT: 7 28 Day Mortality –Standard Therapy: 49.2% –EGDT: 33.3% –ARR: 15.9% –NNT: 7 60 Day Mortality –Standard Therapy: 56.9% –EGDT: 44.3% –ARR: 12.6% –NNT: 8 Rivers et al N Eng J Med: 345(19):

Implementing EGDT Reduces Mortality Carolinas Medical Center - Puskarich et al Crit Care Med 2009;13:R167 –1 year mortality pre-implementation vs post-implementation of EGDT protocol: 49% vs 37% P = 0.04 (ARR 12%, NNT 8) Robert Wood Johnson Medical Center - Trzeciak et al Chest 2006;129(2): –In-hospital mortality pre vs post implementation of EGDT protocol: 43.8% vs 18.2% P =.09 (ARR 25.6%, NNT 4) Loma Linda - Nguyen et al Crit Care Med 2007;35(4): –EGDT Sepsis Bundle if completed decreases in-hospital mortality: 20.8% vs 39.5% P <.01 (ARR 18.7, NNT 6) 20

Do you need the whole package? Isn’t it enough to place a line and do appropriate blood pressure and fluid management? Do I really need to do the whole package if their vital signs stabilize? 21

ScvO2 Just placing a line is not enough Septic patients who were normoxic (ScvO %) had lower mortality rate than those with hypoxia (ScvO2 < 70%) –22% (95% CI 18-27%) vs 40% (95% CI 29-53%) Septic patients who were initially hypoxic but were resuscitated through EGDT and became normoxic within 6 hrs, had similar mortality rates to those who were initially normoxic. –22% (95% CI 18-27%) vs 19% (95% CI 13-25%) Pope et al. Ann Emerg Med January

Cryptic Shock Normalized VS Are Not Enough 86% of standard therapy group had normalization of vitals signs by 6 hrs (MAP > 65, CVP > 8, UOP > 0.5 ml/kg/hr) vs 95% of EGDT group 39.8% had persistent global tissue hypoxia (elevated lactate or ScvO2 < 70) compared to 5% of EGDT group In house mortality for this group with cryptic shock was 56.5% vs 30.5% for EGDT group Otero et al Chest 2006;130:

Sepsis Bundle Goals 1.Initiate CVP/ScvO2 monitoring within 2 hrs 2.Antibiotic administered within 4 hrs 3.EGDT complete within 6 hrs 4.Corticosteroid given if persistently hypotensive despite vasopressors 5.Lactate monitored for clearance Nguyen et al Crit Care Med 2007;35(4):

Sepsis Protocol Identifying Appropriate Patients Nurse Initiated Sepsis Order Set –Labs –Telemetry –Initiation of IVF Activation of Sepsis Protocol if pt persistently hypotensive or lactate > 4. 25

Appropriate Patients Inclusion Criteria: SIRS criteria with known or suspected infection Exclusion Criteria: –Acute cerebral vascular event –Acute coronary syndrome –Acute pulmonary edema –History of congestive heart failure 26

Nurse Initiated Order Set Labs –Lactate drawn first (to avoid prolonged tourniquet time) –cbc, cmp, troponin, blood cxs x 2 –UA - cath UA if unable to void in 30 min Other Studies –Cxr - if respiratory symptoms, RR > 20, or hypoxemia –EKG - if hypotensive, tachycardic, or having chest pain or SOB Telemetry If sbp 4 –Notify MD immediately –Initiate IVF with 20 cc/kg NS IV over 30 min –Re-assess after IVF 27

Sepsis Protocol Initiate if SBP 4 Notify ED Physician Move pt to Room 1 or 2 if available Page out “sepsis protocol in ED now” to: –ED pharmacist –MICU attending –MICU resident 28

Central Line Placement < 2hrs Nursing/EMT will do sterile prep for central line –Discuss planned site and type of catheter with MD –Position the patient –Prep and drape the patient –Open and prep the central line kit –Notify MD that central line is ready for placement MD will place line with Nursing/EMT sterile assistance CVP monitoring to be recorded with vital signs Labs –VBG with lactate off central line –PT/INR, PTT –Type & Screen STAT pcxr for line placement 29

Early Antibiotics < 4hrs Broad Spectrum Ensure blood cxs drawn x 2 ED pharmacist facilitates 30

EGDT Vijay Kairam, University of Utah 31

Summary Sepsis and septic shock are common presentations in the ED Vital signs are vital in defining sepsis Early recognition and prompt treatment of sepsis can significantly reduce mortality 32

Questions? 33